Cencora Inc. (COR)
NYSE · Healthcare · Medical Distribution
Cencora Inc. is a Healthcare company with a market capitalization of $55.67B, a trailing P/E ratio of 21.9, and a dividend yield of 0.80%.
5-Year Price History
Latest Annual Financials · FY ending September 30, 2025
Recent Quarterly Earnings (EPS)
| Quarter | Reported | Actual EPS | Estimate | Surprise |
|---|---|---|---|---|
| Q2 2026 | May 6, 2026 | $4.75 | $4.73 | +0.4% |
| Q1 2025 | February 4, 2026 | $2.87 | $3.39 | -15.3% |
| Q4 2025 | November 5, 2025 | $3.84 | $3.79 | +1.3% |
| Q3 2025 | August 6, 2025 | $4.00 | $3.84 | +4.2% |
| Q2 2025 | May 7, 2025 | $4.42 | $4.10 | +7.8% |
| Q1 2024 | February 5, 2025 | $3.73 | $3.52 | +6.0% |
Other Medical Distribution Stocks
Frequently Asked Questions
What is Cencora Inc.'s market cap?
As of June 29, 2026, Cencora Inc. (COR) has a market capitalization of $55.67B.
What is Cencora Inc.'s P/E ratio?
Cencora Inc. trades at a trailing price-to-earnings (P/E) ratio of 21.9. Its forward P/E is 14.3.
Does Cencora Inc. pay a dividend?
Yes — Cencora Inc. pays a dividend yielding 0.80%, an annual payout of $2.30 per share.
What sector is COR in?
Cencora Inc. is in the Healthcare sector, specifically the Medical Distribution industry.
What was Cencora Inc.'s revenue?
In its latest reported fiscal year (ending September 30, 2025), Cencora Inc. reported revenue of $321.33B and net income of $1.55B.
Ask your own questions about COR
Try mrmarket.ai freeData as of June 29, 2026. Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.